Quick Answer
IMMUCELL CORP /DE/ reported Cash And Cash Equivalents At Carrying Value of $3.81 million for the year ending 2025.
- IMMUCELL CORP /DE/ showed an increase of +1.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from IMMUCELL CORP /DE/'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), IMMUCELL CORP /DE/'s Cash And Cash Equivalents At Carrying Value has grown by 217.3%.
- Historical annual values: Fiscal year 2025: $3.81 million | Fiscal year 2024: $3.76 million | Fiscal year 2023: $978.7 thousand | Fiscal year 2022: $5.79 million | Fiscal year 2021: $10.19 million | Fiscal year 2020: $6.95 million | Fiscal year 2019: $6.29 million | Fiscal year 2018: $2.52 million | Fiscal year 2017: $3.80 million | Fiscal year 2016: $5.15 million | Fiscal year 2015: $1.57 million | Fiscal year 2014: $850.0 thousand | Fiscal year 2013: $2.27 million | Fiscal year 2012: $2.67 million | Fiscal year 2011: $781.5 thousand | Fiscal year 2010: $1.40 million | Fiscal year 2009: $975.5 thousand | Fiscal year 2008: $1.20 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: